Annette W. Fothergill spends much of her time researching Microbiology, Voriconazole, Amphotericin B, Itraconazole and Fluconazole. Her research on Microbiology frequently links to adjacent areas such as Aspergillosis. Her Voriconazole research focuses on Posaconazole in particular.
Her work carried out in the field of Amphotericin B brings together such families of science as In vitro and Fusarium. The Itraconazole study combines topics in areas such as Trichophyton, Trichophyton rubrum and Pharmacology. The concepts of her Fluconazole study are interwoven with issues in Amphotéricine B, Amfotericina B, Candida albicans, Mycosis and Dimorphic fungus.
Microbiology, Fluconazole, Voriconazole, Amphotericin B and Pharmacology are her primary areas of study. Her Microbiology research focuses on In vitro and how it connects with In vivo. She has included themes like Minimum inhibitory concentration, Fungi imperfecti, Mycosis and Candida albicans in her Fluconazole study.
Her Voriconazole research is multidisciplinary, incorporating elements of Murine model, Aspergillus fumigatus, Aspergillosis and Drug resistance. Her study focuses on the intersection of Amphotericin B and fields such as Itraconazole with connections in the field of Ketoconazole and Phaeohyphomycosis. Her Pharmacology research includes elements of Pharmacotherapy, Potency, Terbinafine and Dermatophyte.
The scientist’s investigation covers issues in Microbiology, In vitro, Pharmacology, Voriconazole and In vivo. Caspofungin, Broth microdilution, Amphotericin B, Fluconazole and Corpus albicans are subfields of Microbiology in which her conducts study. Her Fluconazole research focuses on Cryptococcus neoformans and how it relates to Intensive care medicine and Treatment decision making.
Her Pharmacology research integrates issues from Antifungal, Potency, Terbinafine and Candida albicans. Her biological study focuses on Posaconazole. The study incorporates disciplines such as Candida glabrata, Echinocandin and Cryptococcosis in addition to In vivo.
Annette W. Fothergill focuses on Microbiology, Itraconazole, Voriconazole, Pharmacology and Azole. Her Microbiology research incorporates elements of In vitro and Fungus. Her work in Itraconazole addresses issues such as Amphotericin B, which are connected to fields such as Corpus albicans and Broth microdilution.
Her studies deal with areas such as Antifungal drug and Surgery as well as Voriconazole. Her Azole research is multidisciplinary, relying on both Aspergillus fumigatus and Aspergillosis. Her studies in Fluconazole integrate themes in fields like Cryptococcus gattii and Candida glabrata.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Infections Caused by Scedosporium spp.
Karoll J. Cortez;Emmanuel Roilides;Flavio Quiroz-Telles;Joseph Meletiadis.
Clinical Microbiology Reviews (2008)
Fungal rhinosinusitis: A categorization and definitional schema addressing current controversies
Arunaloke Chakrabarti;David W. Denning;Berrylin J. Ferguson;Jens Ponikau.
MOLECULAR PHYLOGENETIC DIVERSITY, MULTILOCUS HAPLOTYPE NOMENCLATURE, AND IN VITRO ANTIFUNGAL RESISTANCE WITHIN THE FUSARIUM SOLANI SPECIES COMPLEX
Kerry O'Donnell;Deanna A. Sutton;Annette Fothergill;Dora McCarthy.
Journal of Clinical Microbiology (2008)
Guide to Clinically Significant Fungi
Deanna A. Sutton;Annette W. Fothergill;Michael G. Rinaldi.
In Vitro Activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 Clinical Isolates of Zygomycetes
Qiu N. Sun;Annette W. Fothergill;Dora I. McCarthy;Michael G. Rinaldi;Michael G. Rinaldi.
Antimicrobial Agents and Chemotherapy (2002)
Resistance of Candida albicans to Fluconazole During Treatment of Oropharyngeal Candidiasis in a Patient with AIDS: Documentation by In Vitro Susceptibility Testing and DNA Subtype Analysis
S. Redding;J. Smith;J. Smith;G. Farinacci;G. Farinacci;M. Rinaldi;M. Rinaldi.
Clinical Infectious Diseases (1994)
In Vitro Amphotericin B Resistance in Clinical Isolates of Aspergillus terreus, with a Head-to-Head Comparison to Voriconazole
Deanna A. Sutton;Stephen E. Sanche;Sanjay G. Revankar;Annette W. Fothergill.
Journal of Clinical Microbiology (1999)
In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents
Nikolaos G. Almyroudis;Deanna A. Sutton;Annette W. Fothergill;Michael G. Rinaldi.
Antimicrobial Agents and Chemotherapy (2007)
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi.
A. Espinel-Ingroff;M. Bartlett;R. Bowden;N. X. Chin.
Journal of Clinical Microbiology (1997)
Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates
William R. Kirkpatrick;Sanjay G. Revankar;Robert K. Mcatee;Jose L. Lopez-Ribot.
Journal of Clinical Microbiology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: